CRISPRMED26 - The 3rd CRISPR MEDiCiNE Conference 2026, April 13th - 16th, Copenhagen, Denmark
Join the Global CRISPR MEDiCiNE Community in Copenhagen - April 13th - 16th 2026
The 3rd edition of the CRISPR MEDiCiNE Conference will take place in Copenhagen, Denmark from April 13th - 16th 2026.
The 3rd CRISPR Medicine Conference including the satellite meetings and the workshops, will take place at CPH Conference Center, located in Vesterbro district of the beautiful city of Copenhagen. Please check the location details here.
This premier annual event shines a spotlight on critical breakthroughs and challenges in CRISPR medicine - from cutting-edge tools and delivery systems to safety, regulation, functional genomics, pre-clinical pipelines, and advances in clinical trials.
Expect:
World-class speakers from academia, biotech and industry
Skill-building workshops to accelerate your career
Live poster sessions (virtual and on-site) to showcase your work
New for 2026: Satellite Meetings built to spark collaboration between stakeholders, networks, and communities across Europe working in the genomic medicine field.
Submit your abstract for a chance to be selected for an oral presentation - or even featured in CRISPR Medicine News, read by 35,000+ professionals monthly.
Ready to join?
Important Dates before the Event
August 1st 2025: Registration & abstract submissions open
December 8th 2025: Early bird registration deadline (EXTENDED TO Jan 12th)
January 12th 2026: Abstract submission deadline (EXTENDED TO Jan. 26th)
February 2026: Oral and poster notifications
March 2026: Final CRISPRMED26 programme available / Travel grant notification / Registration deadline (In-person event)
April 3rd 2026: Registration deadline (In-person Event)
April 10th 2026: Registration deadline (Virtual Event)
April 13th 2026: Abstract publication in the CRISPR Medicine News portal
Why You Should Attend CRISPRMED26 Hybrid
Stay at the Cutting Edge of Gene Editing - Gain the latest insights on CRISPR tools, functional genomics platforms, delivery strategies, in vivo editing, clinical progress, and AI-driven therapeutic development.
Learn from Global Leaders - Engage directly with top researchers, clinicians, biotech innovators, regulators, and patient advocates shaping genomic medicine.
Explore Real-World Applications & Regulations - Understand how CRISPR is translated into therapies and navigate CMC, pre-clinical, and clinical pathways with expert guidance.
Advance Your Career & Skills - Participate in technical workshops, communication challenges, and job-matching sessions to grow professionally.
Connect & Collaborate - Network with 400+ participants, join flash talks, satellite meetings, and founders’ circles to build valuable collaborations.
Experience a Dynamic Format - Take part in interactive panels, social events, and virtual sessions to stay connected and engaged.
Events at CRISPRMED26 Hybrid
Updated programme available here.
April 13th (in-person):
Opening: 11:00 AM CEST
Welcome Lunch: 12:00-13:00 PM CEST (exhibition area)
Exhibition: 13:00 - 21:00 PM CEST
Satellite Meetings: 13:00 - 17:00 PM CEST
Opening Reception/Official launch of EGMEDC: 18:00 - 21:00 PM CEST
April 14th (in-person):
Exhibition: 9:00 - 21:00 PM CEST
Workshops: 9:00 - 10:30 AM CEST
Founders´ Breakfast: 9:00 - 10:30 AM CEST
Scientific Conference In-person Event: 11:00 - 21:00 PM CEST
Scientific Presentations: 11:00 - 18:00 PM CEST (confirmed speakers)
Poster Session, Flash Talks, Exhibitor Evening: 18:00-21:00 CEST
April 15th (in-person):
Panels and Selected Sponsor Events: 9:00-12:00
April 13th (virtual/live streamed):
Scientific Presentations Virtual WDC Event-I: 15:00 - 18:00 PM CEST - Selected speakers and virtual poster session.
April 14th (virtual/live streamed):
Scientific Presentations In-person Event: 11:00 - 17:30 PM CEST (confirmed speakers for the in-person event)
April 15th (virtual/live streamed):
Scientific Presentations Virtual Keynote Session: 15:00 - 18:00 PM CEST.
Social/networking in-person events in Copenhagen will be planned for April 15-16 and included in the registration fee.
All presentations will be recorded and available after the conference to all registrants.
Sponsors and Supporters
Keynote Speakers
Head of the Bone Marrow Aplasia Unit at CIEMAT/CIBERER/IIS-FJD, UAM
Founding Director of the new Columbia Initiative in Cell Engineering and Therapy (CICET) and Director of the Cancer Cell Therapy Initiative in the Herbert Irving Comprehensive Cancer Center
Meet the Speakers
The CRISPRMED Emerging Innovator Fellowship 2026 will be awarded live on stage at CRISPRMED26. This award celebrates one young researcher whose groundbreaking work exemplifies the future of gene-editing therapeutics.
Hosted by NBT
Industry Speakers
Pictures from CRISPRMED25
Questions? Check out our FAQ section or contact CRISPRMED26 staff at info@crisprmedicineconference.com.
Want to be updated on CRISPRMED26's latest news?
Scientific Committee
Özcan Met, PhD, Ass. Prof. and Head of Cell Therapy Unit and DTU HealthTech, CCIT-DK / DTU, Denmark.
Jakob Nilsson, Prof. and Group leader, Danish Cancer Institute, Denmark.
Cecilia Jimenez-Mallebrera, PhD and Research Director, Institut de Recerca Sant Joan de Déu. Hospital Sant Joan de Déu Barcelona and CIBERER, Spain.
Laura Torella, PostDoc, AstraZeneca, Sweden.
Alessia Cavazza, Ass. Prof. and Group leader, Zayed Centre for Research into Rare Diseases in Children, UCL Great Ormond Street Institute of Child Health, University College London, UK.
Organising Committee
Gorm Palmgren, Chief Editor, CRISPR Medicine News
Clarissa Braun, Communications and Project Manager, CRISPR Medicine News
Antonio Carusillo, Science Communication Officer, CRISPR Medicine News
Manel Lladó, Science Communication Officer, CRISPR Medicine News
Martina Franchini, Science Communication Officer, CRISPR Medicine News
Martina Tarozzi, Consultant, CRISPR Medicine News
Jens-Ole Bock, Founder, CRISPR Medicine News/ CRISPRMED Conferences
Abstract Reviewers
Özcan Met, PhD, Ass. Prof. and Head of Cell Therapy Unit and DTU HealthTech, CCIT-DK / DTU, Denmark.
Jakob Nilsson, Prof. and Group leader, Danish Cancer Institute, Denmark.
Cecilia Jimenez-Mallebrera, PhD and Research Director, Institut de Recerca Sant Joan de Déu. Hospital Sant Joan de Déu Barcelona and CIBERER, Spain.
Laura Torella, PostDoc, AstraZeneca, Sweden.
Alessia Cavazza, Ass. Prof. and Group leader, Zayed Centre for Research into Rare Diseases in Children, UCL Great Ormond Street Institute of Child Health, University College London, UK.
Karim Benabdel Lah El Khlanji, Senior Scientist at the GENyO Pfizer-University of Granada-Junta de Andalucia Center for Genomics and Oncological Research in Granada, Spain, GeneHumdi Action Chair.
Jan Gorodkin, Professor and Group Leader at the University of Copenhagen, Denmark.
Julian Grünewald, Assistant Professor and Emmy Noether group leader at Technical University of Munich, Germany.
Dr. Carla Fuster, University of Freiburg, Germany
Anastasia Conti, Postdoc, Project Leader, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Milan, Italy.
Antonio Carusillo, PhD, Senior Postdoctoral Fellow at Fondazione Telethon, Italy, and Science Communication Officer, CRISPR Medicine News.
Location
Hybrid event:
Copenhagen, Denmark
Copenhagen
Denmark
Contact us
If you have any questions, please contact info@crisprmedicineconference.com